Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01JNE
|
||||
Former ID |
DIB016568
|
||||
Drug Name |
Lexibulin iv infusion
|
||||
Synonyms |
Lexibulin; CYT-997; Microtubule inhibitor (oral, solid tumors) Cytopia; VDA anticancer program (iv), Cytopia; Lexibulin (iv infusion, cancer), YM BioSciences; Lexibulin (oral capsule, cancer), YM Biosciences; CYT-997 (iv infusion, cancer), Cytopia; CYT-997 (iv infusion, cancer), YM BioSciences; CYT-997 (oral capsule, cancer), Cytopia; CYT-997 (oral capsule, cancer), YM Biosciences; Vascular disrupting agent/ tubulin inhibitor (iv, cancer), Cytopia; Vascular disrupting agent/tubulin inhibitor (oral, cancer), Cytopia; Vascular targeting agent/ tubulin inhibitor (iv, cancer), Cytopia
|
||||
Indication | Glioblastoma multiforme [ICD9: 191; ICD10:C71] | Phase 2 | [522301] | ||
Company |
Cytopia Ltd; Cytopia
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(c(cnc(n1)c1ccc(c(c1)OC)NC(=O)NCC)C)N[C@H](c1cnccc1)C<br />CC
|
||||
CAS Number |
CAS 917111-44-5
|
||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Inhibitor | [550425] | |
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.